Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Can BigBear.ai Monetize Growth in Travel & Border Security AI?
Can BigBear.ai Monetize Growth in Travel & Border Security AI?

BigBear.ai Holdings, Inc. BBAI is increasingly positioning itself at the intersection of AI, border security and global trade modernization. The key question for investors is whether its expanding

Should You Add More U.K. ETFs to Your Portfolio Now?
Should You Add More U.K. ETFs to Your Portfolio Now?

The FTSE 100 kicked off 2026 on a strong note, building steady upward momentum. U.K.’s benchmark index has risen 7.69% so far this year and 22.75% over the past year, outperforming its transatlantic

Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?

Ironwood Pharmaceuticals IRWD and Bausch Health BHC operate in the branded gastrointestinal (GI) drug market, with a focus on treatments for irritable bowel syndrome (IBS) and other therapeutic

Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump
Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump

Shares of Elite Pharmaceuticals, Inc. ELTP have lost 10.7% since the company reported its earnings for the quarter ended Dec. 31, 2025. This compares with the S&P 500 Index’s 0.2% gain over the same

Hims & Hers Accelerates AI Preventive Care and Platform Strategy
Hims & Hers Accelerates AI Preventive Care and Platform Strategy

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has positioned itself as a leading digital health and wellness platform built around expanding access to personalized

Pre-Markets in Red on Soft Q4 2025 GDP Growth Rate
Pre-Markets in Red on Soft Q4 2025 GDP Growth Rate

Economic indexes had been on a roll lately, putting up better-than-expected figures on growth, productivity, employment and so on. That appears to have come to an end this morning with a slew of

Opendoor Q4 Loss Narrower Than Expected, Revenues Down Y/Y
Opendoor Q4 Loss Narrower Than Expected, Revenues Down Y/Y

Opendoor Technologies Inc. OPEN reported fourth-quarter 2025 results, with adjusted earnings and revenues surpassing the Zacks Consensus Estimate. On a year-over-year basis, the top line decreased

Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Genomics Stocks That Deserve a Place in Your Portfolio in 2026

An updated edition of the Jan. 6, 2026, article.

Genomics is the comprehensive study of genomes—the complete set of deoxyribonucleic acid (DNA) within an organism. Rapid scientific progress in this

AstraZeneca vs. Pfizer: Which Pharma Giant Has the Edge in 2026?
AstraZeneca vs. Pfizer: Which Pharma Giant Has the Edge in 2026?

Pfizer PFE and AstraZeneca AZN are two global pharmaceutical leaders with a commanding presence in oncology. For Pfizer, oncology is a key growth driver, accounting for roughly 27% of total company

Beauty & Cosmetics Growth Story: Radiant Stocks You Should Watch
Beauty & Cosmetics Growth Story: Radiant Stocks You Should Watch

An updated edition of the Dec. 18, 2025, article.The U.S. beauty and cosmetics industry remains one of the more resilient segments within the consumer products space, offering a defensive growth

ETFs to Buy as NVIDIA Nears $30 Billion Investment in OpenAI
ETFs to Buy as NVIDIA Nears $30 Billion Investment in OpenAI

In a significant strategic pivot, NVIDIA NVDA is reportedly in the final stages of negotiating a $30 billion equity investment in OpenAI, part of a blockbuster funding round that could value the

Is Home Depot (HD) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
Is Home Depot (HD) a 'Buy' Ahead of Its Upcoming Earnings Announcement?

Home improvement retailer Home Depot HD is set to announce fourth-quarter earnings results before Tuesday’s opening bell. The company missed the earnings mark in three of the last four quarters. But

Extra Space Storage Q4 Core FFO & Revenues Surpass Estimates
Extra Space Storage Q4 Core FFO & Revenues Surpass Estimates

Extra Space Storage Inc. EXR reported fourth-quarter 2025 core funds from operations (FFO) per share of $2.08, surpassing the Zacks Consensus Estimate of $2.03. The figure increased 2.05% from the

How to Approach Sonic Automotive Stock Post Q4 Earnings?
How to Approach Sonic Automotive Stock Post Q4 Earnings?

Sonic Automotive SAH, one of the leading automotive retailers in the United States, posted fourth-quarter 2025 adjusted earnings per share of $1.52, which increased 1% year over year. Total revenues

ETFs to Watch as Walmart Shares Slip Despite Q4 Earnings Beat
ETFs to Watch as Walmart Shares Slip Despite Q4 Earnings Beat

Shares of Walmart Inc. WMT slipped 1.4% yesterday, following the company’s better-than-expected fourth-quarter fiscal 2026 results. Despite comfortably surpassing analysts’ estimates for earnings

OKLO Stock: What the Near-Term Rating Means for Investors
OKLO Stock: What the Near-Term Rating Means for Investors

Oklo Inc. OKLO offers long-term promise in advanced nuclear, but the near-term setup remains difficult. The stock carries a Zacks Rank #4 (Sell), signaling weak momentum over the next one to three

OKLO Business Model Explained: When Revenue Could Arrive
OKLO Business Model Explained: When Revenue Could Arrive

Oklo Inc. OKLO is not trying to win by selling reactor blueprints. The company is building a utility-like model around small nuclear plants it expects to own and operate, with revenue tied to

Pre-Markets Dip on GDP & PCE Figures
Pre-Markets Dip on GDP & PCE Figures

Friday, February 20th, 2026Economic indexes had been on a roll lately, putting up better-than-expected figures on growth, productivity, employment and so on. That appears to have come to an end this

Insmed Lags on Q4 Earnings, Stock Gains on 2026 Brinsupri Sales View
Insmed Lags on Q4 Earnings, Stock Gains on 2026 Brinsupri Sales View

Insmed INSM reported a fourth-quarter 2025 loss of $1.54 per share, wider than the Zacks Consensus Estimate of a loss of $1.07. In the year-ago quarter, the company had incurred a loss of $1.32.

ETSY Q4 Earnings & Revenues Surpass Estimates, EPS Declines Y/Y
ETSY Q4 Earnings & Revenues Surpass Estimates, EPS Declines Y/Y

Etsy ETSY reported fourth-quarter 2025 earnings of 92 cents per share, which beat the Zacks Consensus Estimate by 4.55% but declined 10.68% year over year.Fourth-quarter 2025 revenues increased

MercadoLibre Set to Report Q4 Earnings: Hold or Fold the Stock?
MercadoLibre Set to Report Q4 Earnings: Hold or Fold the Stock?

MercadoLibre MELI is slated to report fourth-quarter 2025 results on Feb. 24.The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $8.52 billion, suggesting year-over-year growth of

High Yield Revival: 3 Cash-Rich Dividend Payers on Sale
High Yield Revival: 3 Cash-Rich Dividend Payers on Sale

Investors aren’t putting cash under their mattresses, but they’re certainly looking to take some risk off the table. This means rotation out of high-growth technology stocks and looking for value.

LKQ Q4 Earnings Miss Expectations, Revenues Decline Y/Y
LKQ Q4 Earnings Miss Expectations, Revenues Decline Y/Y

LKQ Corporation LKQ delivered fourth-quarter 2025 adjusted earnings of 59 cents per share, which missed the Zacks Consensus Estimate of 65 cents and declined from 80 cents reported in the year-ago

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

ANI Pharmaceuticals (ANIP) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Chart Industries (GTLS) Earnings Expected to Grow: What to Know Ahead of Q4 Release
Chart Industries (GTLS) Earnings Expected to Grow: What to Know Ahead of Q4 Release

The market expects Chart Industries (GTLS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known